Allegion (NYSE:ALLE) updated its FY 2019 earnings guidance on Thursday. The company provided EPS guidance of $4.80-4.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.86. The company issued revenue guidance of $2.8546265-2.8819435 billion, compared to the consensus revenue estimate of $2.89 billion.Allegion also updated its FY19 guidance to $4.80-4.90 EPS.

Shares of NYSE ALLE traded up $0.45 during trading hours on Friday, hitting $105.26. The stock had a trading volume of 858,010 shares, compared to its average volume of 628,862. The firm has a market capitalization of $9.85 billion, a P/E ratio of 23.39, a P/E/G ratio of 1.87 and a beta of 1.18. The company’s 50-day moving average price is $108.02. Allegion has a 52 week low of $74.83 and a 52 week high of $111.99. The company has a quick ratio of 1.14, a current ratio of 1.71 and a debt-to-equity ratio of 2.10.

Allegion (NYSE:ALLE) last announced its quarterly earnings results on Thursday, July 25th. The scientific and technical instruments company reported $1.26 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.31 by ($0.05). The firm had revenue of $731.20 million during the quarter, compared to the consensus estimate of $750.76 million. Allegion had a net margin of 15.65% and a return on equity of 68.47%. The company’s quarterly revenue was up 3.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.19 EPS. Equities research analysts anticipate that Allegion will post 4.85 earnings per share for the current fiscal year.

ALLE has been the subject of several recent research reports. Bank of America set a $10.00 price target on HEXO and gave the company a buy rating in a research note on Thursday, June 13th. ValuEngine cut Zosano Pharma from a buy rating to a hold rating in a research note on Wednesday, May 1st. Barclays boosted their price target on Roper Technologies from $342.00 to $355.00 and gave the company an equal weight rating in a research note on Tuesday, July 9th. Imperial Capital cut Lionsgate to an in-line rating and lowered their price target for the company from $24.00 to $16.00 in a research note on Monday, April 29th. Finally, Credit Suisse Group reissued a hold rating on shares of FactSet Research Systems in a research note on Monday, July 8th. Five equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The company currently has a consensus rating of Hold and an average price target of $103.50.

In related news, CAO Douglas P. Ranck sold 3,036 shares of the business’s stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $104.64, for a total value of $317,687.04. Following the completion of the sale, the chief accounting officer now directly owns 5,442 shares in the company, valued at approximately $569,450.88. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Jeffrey N. Braun sold 6,218 shares of the business’s stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $104.44, for a total value of $649,407.92. Following the completion of the sale, the senior vice president now owns 13,394 shares of the company’s stock, valued at $1,398,869.36. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 14,611 shares of company stock valued at $1,498,349. Corporate insiders own 0.77% of the company’s stock.

About Allegion

Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door closers and controls; doors and door systems; electronic security products; electronic, biometric and mobile access control systems; exit devices; locks, locksets, portable locks, and key systems; time, attendance, and workforce productivity systems; and other accessories.

Recommended Story: Return on Equity (ROE)

Earnings History and Estimates for Allegion (NYSE:ALLE)

Receive News & Ratings for Allegion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allegion and related companies with's FREE daily email newsletter.